Reply to Dr Michaud et al.
Neurologia I, Istituto Neurologico Carlo Besta, Milano, Italy.
A E
AE
Elia
UO Neurogenetica Molecolare, Fondazione IRCCS Istituto Neurologico 'C. Besta', Milano, Italy.|MRC Mitochondrial Biology Unit, Cambridge, UK.
C
C
Viscomi
Centro Regionale SLA, AOUP 'P. Giaccone', Università di Palermo, Palermo, Italy.
V
V
La Bella
Neurologia I, Seconda Università di Napoli, Napoli, Italy.
G
G
Tedeschi
Neurologia I, Istituto Neurologico Carlo Besta, Milano, Italy.|Istituto di Neurologia, Università Cattolica del Sacro Cuore, Milano, Italy.
A
http://orcid.org/0000-0002-5864-0006
A
Albanese
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D000818:Animals; D002756:Cholagogues and Choleretics / Q000494:pharmacology*; D004721:Endoplasmic Reticulum / Q000502:physiology*; D006801:Humans; D013655:Taurochenodeoxycholic Acid / Q000494:pharmacology*; D056811:Unfolded Protein Response / Q000502:physiology*
D002756:Cholagogues and Choleretics; D013655:Taurochenodeoxycholic Acid
amyotrophic lateral sclerosis; mitochondria; tauroursodeoxycholic acid